169 related articles for article (PubMed ID: 32173)
21. Primary structure and inhibitory properties of a subtilisin-chymotrypsin inhibitor from Streptomyces virginiae.
Terabe M; Kojima S; Taguchi S; Momose H; Miura K
Eur J Biochem; 1994 Dec; 226(2):627-32. PubMed ID: 8001578
[TBL] [Abstract][Full Text] [Related]
22. The propeptide of subtilisin BPN' as a temporary inhibitor and effect of an amino acid replacement on its inhibitory activity.
Kojima S; Minagawa T; Miura K
FEBS Lett; 1997 Jul; 411(1):128-32. PubMed ID: 9247157
[TBL] [Abstract][Full Text] [Related]
23. Effects of deletion in the flexible loop of the protease inhibitor SSI (Streptomyces subtilisin inhibitor) on interactions with proteases.
Kojima S; Furukubo S; Kumagai I; Miura K
Protein Eng; 1993 Apr; 6(3):297-303. PubMed ID: 8506264
[TBL] [Abstract][Full Text] [Related]
24. Primary structure and inhibitory properties of a proteinase inhibitor produced by Streptomyces cacaoi.
Kojima S; Terabe M; Taguchi S; Momose H; Miura K
Biochim Biophys Acta; 1994 Jul; 1207(1):120-5. PubMed ID: 8043602
[TBL] [Abstract][Full Text] [Related]
25. Stabilized variant of Streptomyces subtilisin inhibitor and its use in stabilizing subtilisin BPN'.
Ganz PJ; Bauer MD; Sun Y; Fieno AM; Grant RA; Correa PE; Laskowski M; Saunders CW
Protein Eng Des Sel; 2004 Apr; 17(4):333-9. PubMed ID: 15187224
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure at 2.6 A resolution of the complex of subtilisin BPN' with streptomyces subtilisin inhibitor.
Hirono S; Akagawa H; Mitsui Y; Iitaka Y
J Mol Biol; 1984 Sep; 178(2):389-414. PubMed ID: 6387152
[TBL] [Abstract][Full Text] [Related]
27. Contribution of long-range electrostatic interactions to the stabilization of the catalytic transition state of the serine protease subtilisin BPN'.
Jackson SE; Fersht AR
Biochemistry; 1993 Dec; 32(50):13909-16. PubMed ID: 8268166
[TBL] [Abstract][Full Text] [Related]
28. Molecular recognition at the active site of subtilisin BPN': crystallographic studies using genetically engineered proteinaceous inhibitor SSI (Streptomyces subtilisin inhibitor).
Takeuchi Y; Noguchi S; Satow Y; Kojima S; Kumagai I; Miura K; Nakamura KT; Mitsui Y
Protein Eng; 1991 Jun; 4(5):501-8. PubMed ID: 1891457
[TBL] [Abstract][Full Text] [Related]
29. Comparison of spectral and structural properties of three homologous dimeric proteins.
Komiyama T; Kanno H; Honbou K; Miwa M
Biochim Biophys Acta; 1987 Jul; 914(1):89-95. PubMed ID: 3300780
[TBL] [Abstract][Full Text] [Related]
30. Stoichiometry of the interaction of human plasma alpha 1-proteinase inhibitor with subtilisin BPN'.
Abe O; Kuromizu K
J Biochem; 1989 Jan; 105(1):66-71. PubMed ID: 2661553
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of temporary inhibition in Streptomyces subtilisin inhibitor induced by an amino acid substitution, tryptophan 86 replaced by histidine.
Tamura A; Kanaori K; Kojima S; Kumagai I; Miura K; Akasaka K
Biochemistry; 1991 May; 30(21):5275-86. PubMed ID: 2036394
[TBL] [Abstract][Full Text] [Related]
32. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
Longstaff C; Campbell AF; Fersht AR
Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
[TBL] [Abstract][Full Text] [Related]
33. Alteration of inhibitory properties of Pleurotus ostreatus proteinase A inhibitor 1 by mutation of its C-terminal region.
Kojima S; Hisano Y; Miura K
Biochem Biophys Res Commun; 2001 Mar; 281(5):1271-6. PubMed ID: 11243873
[TBL] [Abstract][Full Text] [Related]
34. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to human leukocyte elastase, bovine alpha-chymotrypsin and subtilisin Carlsberg: thermodynamic study.
Ascenzi P; Amiconi G; Menegatti E; Guarneri M; Bolognesi M; Schnebli HP
J Enzyme Inhib; 1988; 2(3):167-72. PubMed ID: 3071573
[TBL] [Abstract][Full Text] [Related]
35. The reactive site of Streptomyces subtilisin inhibitor.
Omichi K; Nagura N; Ikenaka T
J Biochem; 1980 Feb; 87(2):483-9. PubMed ID: 6987215
[TBL] [Abstract][Full Text] [Related]
36. Folding of subtilisin BPN': characterization of a folding intermediate.
Eder J; Rheinnecker M; Fersht AR
Biochemistry; 1993 Jan; 32(1):18-26. PubMed ID: 8418836
[TBL] [Abstract][Full Text] [Related]
37. Three novel subtilisin-trypsin inhibitors from Streptomyces: primary structures and inhibitory properties.
Terabe M; Kojima S; Taguchi S; Momose H; Miura K
J Biochem; 1994 Nov; 116(5):1156-63. PubMed ID: 7896747
[TBL] [Abstract][Full Text] [Related]
38. Equilibrium study on the binding between thermolysin and Streptomyces metalloprotease inhibitor, talopeptin (MKI).
Kitagishi K; Hiromi K; Oda K; Murao S
J Biochem; 1983 Jan; 93(1):47-53. PubMed ID: 6341369
[TBL] [Abstract][Full Text] [Related]
39. Achievement of renaturation of subtilisin BPN' by a novel procedure using organic salts and a digestible mutant of Streptomyces subtilisin inhibitor.
Matsubara M; Kurimoto E; Kojima S; Miura K; Sakai T
FEBS Lett; 1994 Apr; 342(2):193-6. PubMed ID: 8143876
[TBL] [Abstract][Full Text] [Related]
40. Kinetics and energetics of the binding between barley alpha-amylase/subtilisin inhibitor and barley alpha-amylase 2 analyzed by surface plasmon resonance and isothermal titration calorimetry.
Nielsen PK; Bønsager BC; Berland CR; Sigurskjold BW; Svensson B
Biochemistry; 2003 Feb; 42(6):1478-87. PubMed ID: 12578360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
